SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-021535
Filing Date
2019-11-05
Accepted
2019-11-05 10:01:20
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20190930_10q.htm 10-Q 1382496
2 EXHIBIT 31.1 ex_155892.htm EX-31.1 14854
3 EXHIBIT 31.2 ex_155893.htm EX-31.2 14834
4 EXHIBIT 32 ex_155894.htm EX-32 5993
  Complete submission text file 0001437749-19-021535.txt   5610306

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxfd-20190930.xml EX-101.INS 1072416
6 XBRL TAXONOMY EXTENSION SCHEMA oxfd-20190930.xsd EX-101.SCH 53496
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxfd-20190930_cal.xml EX-101.CAL 66964
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxfd-20190930_def.xml EX-101.DEF 377410
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxfd-20190930_lab.xml EX-101.LAB 319302
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxfd-20190930_pre.xml EX-101.PRE 403875
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 191192026
SIC: 2835 In Vitro & In Vivo Diagnostic Substances